Biocompatibility Concerns with NuVasive Precice Devices

All Precice devices have materials that are undergoing additional biocompatibility testing.

If your email program has trouble displaying this email, view as a webpage. Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics' Precice Devices – Letter to Health Care Providers Today, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers with information on potential biocompatibility concerns associated with stainless steel and titanium-based orthopedic devices manufactured by NuVasive Specialized Orthopedics. Read More The Letter to Health Care Providers includes: Recommendations for health care providers. Actions the FDA is taking to address issues with Precice devices. Instructions for reporting problems with Precice devices to the FDA. Questions? If you have questions about this letter to health care providers, contact the Division of Industry and Consumer Education (DICE).

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA